What recommendations are appropriate for a patient using adaptive servo‑ventilation (ASV) who is experiencing frequent burping?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 17, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Managing Burping (Aerophagia) in Patients on Adaptive Servo-Ventilation

For patients experiencing burping on ASV, reduce the expiratory positive airway pressure (EPAP) to the lowest effective level, consider switching to auto-EPAP mode if available, and ensure proper mask fit to minimize air swallowing.

Understanding the Problem

Burping during ASV therapy is typically caused by aerophagia—the swallowing of air that occurs when positive airway pressure forces air into the esophagus and stomach rather than exclusively into the lungs. This is a common and bothersome side effect that can significantly impact therapy adherence and quality of life.

Immediate Troubleshooting Steps

1. Pressure Optimization

  • Lower the EPAP setting to the minimum level that still controls obstructive events
  • Current ASV algorithms allow for variable EPAP (unlike older fixed-EPAP devices), which can help minimize excessive pressure 1
  • Start by reducing EPAP by 1-2 cmH₂O increments and reassess symptoms
  • The goal is finding the lowest pressure that maintains airway patency without causing aerophagia

2. Switch to Auto-EPAP Mode

  • If your ASV device has auto-adjusting EPAP capability, activate this feature
  • Auto-EPAP adjusts pressure dynamically throughout the night, using higher pressures only when needed
  • Real-world data shows auto-EPAP usage varies by patient phenotype and can reduce overall pressure exposure 1

3. Mask Interface Assessment

  • Check for proper mask fit—leaks can cause mouth breathing and increased air swallowing
  • Consider switching mask types (nasal pillows → nasal mask → full face mask, or vice versa)
  • Ensure the mask is not overtightened, which paradoxically can worsen leaks and aerophagia

Device-Specific Considerations

Modern ASV devices differ in their algorithms:

  • Servo-controlled volume devices (e.g., ResMed) adjust pressure support based on target minute ventilation
  • Servo-controlled flow devices (e.g., Philips) respond to flow patterns
  • These differences can affect delivered pressures and aerophagia risk 1

If burping persists despite optimization, discuss with your equipment provider whether switching ASV device types might help, as different algorithms may suit individual patients better.

Clinical Context from Guidelines

The 2025 AASM guidelines emphasize that treatment decisions should prioritize patient-reported outcomes and quality of life improvement rather than solely focusing on eliminating respiratory events 2. Burping that impairs quality of life or threatens adherence warrants aggressive troubleshooting, as ASV effectiveness depends on consistent nightly use.

Common Pitfalls to Avoid

  • Don't ignore the complaint—aerophagia can lead to therapy abandonment
  • Don't assume higher pressure is always better—excessive pressure increases aerophagia risk without additional therapeutic benefit
  • Don't overlook simple solutions—sometimes just changing eating patterns (avoiding large meals close to bedtime) helps
  • Don't delay follow-up—persistent aerophagia requires device download review and possible in-lab titration

When to Escalate

If burping persists despite these interventions:

  • Schedule an in-laboratory ASV titration study to directly observe pressure requirements and aerophagia
  • Review device download data for excessive pressures or inappropriate ventilation patterns
  • Consider alternative therapies if ASV cannot be tolerated (bilevel PAP with backup rate, CPAP for treatment-emergent CSA, or other modalities per guidelines 2)

Monitoring for Hyperventilation

While addressing aerophagia, be aware that inappropriate ASV settings can cause hyperventilation, which carries its own risks 1. Device downloads should show minute ventilation within normal ranges (typically 6-10 L/min for most adults). If minute ventilation is consistently elevated (>12 L/min), pressure support may need reduction regardless of residual apnea events.

The key principle: ASV therapy must be tolerable to be effective. Optimizing pressures to minimize side effects while maintaining therapeutic benefit is essential for long-term adherence and improved outcomes 2, 3.

Related Questions

A patient using adaptive servo‑ventilation (ASV) set at 7–15 cm H₂O has an average residual hypopnea index of 6.2 events per hour and is experiencing mask leaks; what management steps should be taken?
When is Adaptive Servo-Ventilation (ASV) preferred over Bilevel Positive Airway Pressure (BiPAP)?
What are the indications, recommended settings, and contraindications for using Adaptive Servo‑Ventilation (ASV) in patients with central or complex sleep apnea?
In a patient using an Aircurve 10 adaptive servo‑ventilation (ASV) device with minimum EPAP 6 cmH₂O, maximum EPAP 15 cmH₂O, pressure support range 0–15 cmH₂O, average nightly use 4 h 26 min (43% of nights ≥4 h), median leak within normal limits, and an apnea‑hypopnea index (AHI) of 13.1, what adjustments to the EPAP, pressure support, and adherence strategy are recommended?
If 100 mL of normal saline is to be infused over 25 minutes and 1 mL equals 20 drops, what is the drop rate per minute?
What are the treatment options for an atrial septal defect (ASD)?
Are there any medical indications for administering testosterone to a female patient?
What is the differential diagnosis for influenza A in an otherwise healthy adolescent presenting with acute fever, chills, myalgias, headache, sore throat, cough, and fatigue of less than 48 hours?
In an 11‑month‑old infant who tested positive for human coronavirus OC43 and is currently mildly ill with runny nose, cough, and nocturnal low‑grade fever, how long is the expected course of the infection?
What does a uric acid concentration of 7.5 mg/dL in elbow bursal fluid indicate and how should it be managed?
What is the appropriate management for a 50-year-old woman who developed shingles two days ago and has been started on oral valacyclovir?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.